&Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Buy
13,962
+852
+6% +$157K 0.01% 889
2026
Q1
$2.51M Buy
13,110
+2,418
+23% +$509K 0.01% 803
2025
Q4
$2.12M Buy
10,692
+192
+2% +$38.8K 0.01% 826
2025
Q3
$2.13M Sell
10,500
-609
-5% -$108K 0.01% 721
2025
Q2
$1.96M Sell
11,109
-588
-5% -$88.5K 0.02% 677
2025
Q1
$1.68M Buy
11,697
+2,010
+21% +$265K 0.02% 609
2024
Q4
$1.19M Buy
9,687
+1,979
+26% +$294K 0.01% 695
2024
Q3
$1.28M Buy
+7,708
New +$1.17M 0.02% 474

Other funds holding THC

&Partners's THC Position: Q2 2026 in Review

&Partners increased its Tenet Healthcare (THC) stake by 6.5% in Q2 2026, buying an estimated $157K and bringing the position to 13,962 shares worth $2.63M. The position accounts for 0.01% of the portfolio, ranked #889.

&Partners first reported a position in THC in Q3 2024 and has held it in 8 quarters since. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • &Partners held 13,962 shares of Tenet Healthcare worth $2.63M as of Q2 2026.
  • &Partners bought 852 Tenet Healthcare shares in Q2 2026, an estimated $157K.
  • Tenet Healthcare made up 0.01% of &Partners's portfolio in Q2 2026, its #889 holding.
  • &Partners first reported a position in Tenet Healthcare in Q3 2024 and has held it in 8 quarters since.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.